Showing results (131-140 of 214) with videos related to
Sort By:
Pageof 22
ESC Heart Failure|February 19, 2026
Medical treatments at 6 months in hospitalized and ambulatory HFrEF patients in the BRING-UP 3 Heart Failure studyFabrizio Oliva, Francesco Orso, Furio Colivicchi, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 31, 2018
Long-term progression of rhythm and conduction disturbances in pacemaker recipients: findings from the Pacemaker Expert Programming studyPietro Palmisano, Matteo Ziacchi, Ernesto Ammendola, et al.Giornale Italiano Di Cardiologia (2006)|October 4, 2018
[Appropriateness criteria for the management of anticoagulant therapy in complex patients with atrial fibrillation. The opinion of a group of expert Italian cardiologists]Giovanni Luca Botto, Luigi Padeletti, Fabrizio Ammirati, et al.Journal of Cardiovascular Electrophysiology|January 30, 2009
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic eventsGiovanni L Botto, Luigi Padeletti, Massimo Santini, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 14, 2017
Economic impact of remote monitoring after implantable defibrillators implantation in heart failure patients: an analysis from the EFFECT studyAlessandro Capucci, Antonio De Simone, Mario Luzi, et al.American Heart Journal|June 2, 2007
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial FibrillationRobby Nieuwlaat, S Bertil Olsson, Gregory Y H Lip, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 21, 2019
Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillationGiuseppe Boriani, Carina Blomström-Lundqvist, Stefan H Hohnloser, et al.Giornale Italiano Di Cardiologia (2006)|March 25, 2025
[Role of inflammation in heart failure with preserved ejection fraction: from nephro-metabolic interactions to future therapeutic implications]Emilia D'Elia, Manuela Benvenuto, Ilaria Battistoni, et al.Pacing and Clinical Electrophysiology : PACE|August 3, 2007
Duration of P-wave is associated with atrial fibrillation hospitalizations in patients with atrial fibrillation and paced for bradycardiaLuigi Padeletti, Massimo Santini, Giuseppe Boriani, et al.Heart Rhythm|June 14, 2016
Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD)Federico Guerra, Pietro Palmisano, Gabriele Dell'Era, et al.Pageof 22